AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India

OBJECTIVE: To determine the therapeutic efficacy and safety of AYUSH-64 as an add-on to standard care in mild to moderate COVID-19. DESIGN SETTING, AND INTERVENTIONS: This open-label randomized controlled parallel-group trial was conducted at a designated COVID care centre in India in 80 patients di...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Harbans, Srivastava, Sumit, Yadav, Babita, Rai, Amit K., Jameela, Sophia, Muralidharan, Sanuj, Mohan, Rijin, Chaudhary, Shikha, Singhal, Richa, Rana, Rakesh, Khanduri, Shruti, Sharma, Bhagwan S., Chandrasekhararao, Bhogavalli, Srikanth, Narayanam, Chaturvedi, Sarika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824368/
https://www.ncbi.nlm.nih.gov/pubmed/35149205
http://dx.doi.org/10.1016/j.ctim.2022.102814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824368/
https://www.ncbi.nlm.nih.gov/pubmed/35149205
http://dx.doi.org/10.1016/j.ctim.2022.102814

Ejemplares similares